“The stem cells were unable to self-renew, which resulted in long-term and irreversible impairment of tumour growth. In other words, the cancer was permanently shut down.”
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
“This is the first step toward clinically applying the principles of cancer stem cell biology to control cancer growth and advance the development of durable cures,” says principal investigator Dr. John Dick about the findings published online today in Nature Medicine.
He talks about the research in this video.
https://www.youtube.com/watch?v=QK7JquljkBc.
Dr. Dick pioneered the cancer stem cell field by first identifying leukemia stem cells (1994) and colon cancer stem cells (2007). He is also renowned for isolating a human blood stem cell in its purest form – as a single stem cell capable of regenerating the entire blood system – paving the way for clinical use (2011). Dr. Dick holds a Canada Research Chair in Stem Cell Biology and is a Senior Scientist at University Health Network’s Princess Margaret Cancer Centre and McEwen Centre for Regenerative Medicine. He is also a Professor in the Department of Molecular Genetics, University of Toronto, and Director of the Cancer Stem Cell Program at the Ontario Institute for Cancer Research.
In pre-clinical experiments, the research team replicated human colon cancer in mice to determine if specifically targeting the stem cells was clinically relevant. First, the researchers identified that the gene BMI-1, already implicated in maintaining stem cells in other cancers, is the pivotal regulator of colon cancer stem cells and drives the cycle of self-renewal, proliferation and cell survival. Next, the team used an existing small-molecule inhibitor to successfully block BMI-1, thus demonstrating the clinical relevance of this approach.
Lead author Dr. Antonija Kreso writes: “Inhibiting a recognized regulator of self-renewal is an effective approach to control tumor growth, providing strong evidence for the clinical relevance of self-renewal as a biological process for therapeutic targeting.”
Dr. Dick explains: “When we blocked the BMI-1 pathway, the stem cells were unable to self-renew, which resulted in long-term and irreversible impairment of tumour growth. In other words, the cancer was permanently shut down.”
The Latest Google Headlines on: Colon cancer
[google_news title=”” keyword=”Colon cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on: Colon cancer
- Liver protein could be key to preventing spread of colorectal and other cancers, CWRU researchers sayon April 17, 2024 at 4:52 pm
When secreted from the liver, the protein promotes colon cancer-cell growth. Blocking it could treat the disease.
- Colon Cancer Linked to Mouth Bacteriaon April 15, 2024 at 4:29 am
Genomic research of Fusobacterium nucleatum isolated from colon cancer tumors may help researchers develop future screening tests and cancer vaccines
The Latest Google Headlines on: Therapeutic stem cells
[google_news title=”” keyword=”therapeutic stem cells” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on: Therapeutic stem cells
- Valley Stream boy, 8, is first in New York State to receive new therapy for blood disorderon April 19, 2024 at 5:00 am
The new treatment allows children like Yusef to stop taking the blood transfusions that keep the disease at bay.
- Cell Therapy Technologies market is projected to grow at a CAGR of 10.7% by 2034: Visiongainon April 19, 2024 at 4:48 am
Visiongain has published a new report entitled Cell Therapy Technologies Market Report 2024-2034: Forecasts by Product (Sera, Media, Reagent, Cell Engineering Product, Cell Culture Vessels, Equipment, ...
- SCG Cell Therapy and A*STAR Collaborate on Scalable GMP Manufacturing of Cellular Immunotherapieson April 18, 2024 at 7:00 pm
SCG says it has developed in-house cGMP manufacturing capabilities to supply high-quality cell therapy products to patients.
- New gene therapy eliminates need for bone marrow transplant. Here's how it works.on April 18, 2024 at 3:51 pm
A young Long Island boy is the first in New York state to undergo a new gene therapy for a rare blood disease.
- 8-year-old boy first in NY to receive FDA-approved gene therapy for rare inherited blood disorderon April 18, 2024 at 1:55 pm
Yusuf is making history as the first patient in the state of New York to undergo an FDA-approved gene therapy for a rare inherited blood disorder called beta-thalassemia.
- Shinobi strikes deal with electronics powerhouse Panasonic to create new cell therapy manufacturing platformon April 18, 2024 at 1:01 pm
History is coming full circle as induced pluripotent stem (iPS) cell-derived cell therapy maker Shinobi Therapeutics links up with Panasonic and Japan’s Kyoto University, where the first mouse iPS | ...
- Immunotherapy Regenerative Medicine Clinic on Using Stem Cells to Activate the Body's Natural Healing Poweron April 18, 2024 at 10:02 am
Stem cell therapy, a cornerstone of regenerative medicine, has shown immense potential in treating autoimmune diseases, aging conditions, and ...
- Stem Cells Newson April 10, 2024 at 5:00 pm
Feb. 7, 2024 — A tiny microfluidic device can improve cell therapy techniques for spinal cord injury patients. The device can remove a large percentage of stem cells that have not yet fully ...
- This Startup Wants To Be OpenAI Of Stem Cell Therapy, Targets $250B Marketon April 10, 2024 at 6:00 am
Somite.ai aims to improve the lives of millions of people by leveraging AI to produce human tissue for cell therapies.
- What are stem cells and how do they work in therapy?on April 9, 2024 at 10:30 pm
Stem cells offer hope in cancer treatment. India adopts regenerative therapy, focusing on personalized, targeted interventions. Pharmaceutical sector drives innovation for effective therapies.